R & d- dose DE-escalation trial to identify the lowest commercially available dose of linaclotide that maintains bioactivity in rectal mucosa
Ended Awarded Last action
- Contract number
- HHSN26100005
- Awardee
-
Mayo Clinic UEI Y2K4F9RPRRG7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $165,774
Award facts
- Opportunity
-
- N01CN0501469 Solicitation number
- Contract value 100% obligated
- $165,774.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 8 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Rochester, MN 55905, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$82,322 | |
| Exercise an Option | $38,280 | |
| Original award | $209,816 |
Quick answers
Who was awarded contract HHSN26100005?
HHSN26100005 was awarded to Mayo Clinic by National Cancer Institute (National Institutes of Health) on September 1, 2014.
How much is contract HHSN26100005 worth?
The government has obligated $165,774 on HHSN26100005.
Is contract HHSN26100005 an order under another contract?
Yes. HHSN26100005 is a delivery order under HHSN261201200042I, an indefinite delivery contract.
Was contract HHSN26100005 competed?
The extent of competition for HHSN26100005 was full and open competition. The government received 8 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award